Matthew J. Wolf, MD, PhD

Associate Professor
University of Virginia

Presentation(s):

• SGLT2 inhibition improves novel CMR biomarkers of proinflammatory epicardial adipose tissue, the adenosine coronary microvascular response, and diastolic function in a mouse model of early-stage cardiometabolic HFpEF

  Thursday, January 30, 2025
  8:40 AM – 8:50 AM East Coast USA Time